loadpatents
name:-0.033808946609497
name:-0.027382850646973
name:-0.0097179412841797
KRISHNA; Gopal Patent Filings

KRISHNA; Gopal

Patent Applications and Registrations

Patent applications and USPTO patent grants for KRISHNA; Gopal.The latest application filed is for "treating infections with ceftolozane/tazobactam in subjects having impaired renal function".

Company Profile
8.20.26
  • KRISHNA; Gopal - Stow MA
  • KRISHNA; Gopal - Randolph NJ
  • Krishna; Gopal - Parsippany NJ
  • KRISHNA; Gopal - North Brunswick NJ
  • KRISHNA; Gopal - Bellevue WA
  • Krishna; Gopal - San Jose CA
  • Krishna, Gopal - Faridabad ID
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treating Infections With Ceftolozane/tazobactam In Subjects Having Impaired Renal Function
App 20220054460 - KRISHNA; Gopal ;   et al.
2022-02-24
Pharmaceutical Compositions And Methods For Producing Low Impurity Concentrations Of The Same
App 20220000849 - MOTHERAM; Rajeshwar ;   et al.
2022-01-06
Pharmaceutical compositions and methods for producing low impurity concentrations of the same
Grant 11,058,672 - Motheram , et al. July 13, 2
2021-07-13
Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
Grant 10,933,053 - Krishna , et al. March 2, 2
2021-03-02
High purity oritavancin and method of producing same
Grant 10,864,249 - Rafai Far , et al. December 15, 2
2020-12-15
Treating Infections With Ceftolozane/tazobactam In Subjects Having Impaired Renal Function
App 20200093803 - KRISHNA; Gopal ;   et al.
2020-03-26
High Purity Oritavancin And Method Of Producing Same
App 20190290723 - RAFAI FAR; Adel ;   et al.
2019-09-26
Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
Grant 10,376,496 - Krishna , et al. A
2019-08-13
High purity oritavancin and method of producing same
Grant 10,328,118 - Rafai Far , et al.
2019-06-25
Pharmaceutical Compositions and Methods for Stabilizing the Same
App 20190117660 - Krishna; Gopal ;   et al.
2019-04-25
Pharmaceutical Compositions And Methods For Producing Low Impurity Concentrations Of The Same
App 20190091212 - Motheram; Rajeshwar ;   et al.
2019-03-28
Oritavancin Formulations
App 20170239323 - Griffith; David C. ;   et al.
2017-08-24
High Purity Oritavancin And Method Of Producing Same
App 20170157206 - RAFAI FAR; Adel ;   et al.
2017-06-08
High purity oritavancin and method of producing same
Grant 9,649,352 - Rafai Far , et al. May 16, 2
2017-05-16
Treating Infections with Ceftolozane/Tazobactam in Subjects Having Impaired Renal Function
App 20160113910 - Krishna; Gopal ;   et al.
2016-04-28
High Purity Oritavancin And Method Of Producing Same
App 20160015772 - Rafai Far; Adel ;   et al.
2016-01-21
ORAL PHARMACEUTICAL COMPOSITIONS IN A SOLID DISPERSION COMPRISING PREFERABLY POSACONAZOLE AND HPMCAs
App 20150150990 - FANG; Larry Yun ;   et al.
2015-06-04
Treating Infections with Ceftolozane/Tazobactam in Subjects Having Impaired Renal Function
App 20150072968 - Krishna; Gopal ;   et al.
2015-03-12
Pharmaceutical Compositions And Methods For Producing Low Impurity Concentrations Of The Same
App 20140005233 - Motheram; Rajeshwar ;   et al.
2014-01-02
Pharmaceutical Compositions And Methods For Producing Low Impurity Concentrations Of The Same
App 20120322835 - Motheram; Rajeshwar ;   et al.
2012-12-20
Pharmaceutical Compositions And Methods For Stabilizing The Same
App 20120322836 - Krishna; Gopal ;   et al.
2012-12-20
Systems And Methods For Training Document Analysis System For Automatically Extracting Data From Documents
App 20110258150 - NEOGI; Depankar ;   et al.
2011-10-20
Systems And Methods For Automatically Extracting Data From Eletronic Documents Using Multiple Character Recognition Engines
App 20110255784 - WELLING; Girish ;   et al.
2011-10-20
Systems And Methods For Automatically Extracting Data From Electronic Documents Containing Multiple Layout Features
App 20110255789 - NEOGI; Depankar ;   et al.
2011-10-20
High Density Compositions Containing Posaconazole And Formulations Comprising The Same
App 20110123627 - Fang; Larry Yun ;   et al.
2011-05-26
Ready-to-use Bivalirudin Compositions
App 20110046063 - PALEPU; Nagesh ;   et al.
2011-02-24
Ready-to-use bivalirudin compositions
Grant 7,803,762 - Palepu , et al. September 28, 2
2010-09-28
Ready-to-use bivalirudin compositions
Grant 7,713,928 - Palepu , et al. May 11, 2
2010-05-11
Pharmaceutical Compositions And Methods For Producing Low Impurity Concentrations Of The Same
App 20100113534 - Motheram; Rajeshwar ;   et al.
2010-05-06
Pharmaceutical compositions and methods for stabilizing the same
App 20100105743 - Krishna; Gopal ;   et al.
2010-04-29
Pharmaceutical formulations of bivalirudin and processes of making the same
Grant 7,598,343 - Krishna , et al. October 6, 2
2009-10-06
Particulate-stabilized injectable pharmacutical compositions of posaconazole
App 20090226527 - Witchey-Lakshmanan; Leonore ;   et al.
2009-09-10
Pharmaceutical formulations of bivalirudin and processes of making the same
Grant 7,582,727 - Krishna , et al. September 1, 2
2009-09-01
Data communication system with hardware protocol parser and method therefor
Grant 7,293,113 - Krishna , et al. November 6, 2
2007-11-06
Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
App 20060160823 - Witchey-Lakshmanan; Leonore ;   et al.
2006-07-20
Selective address table aging in a network switch based on application state determined from a received data packet
Grant 7,002,955 - Kanuri , et al. February 21, 2
2006-02-21
Particulate-stabilized injectable pharmacutical compositions of posaconazole
App 20060009469 - Witchey-Lakshmanan; Leonore ;   et al.
2006-01-12
Arrangement for searching packet policies using multi-key hash searches in a network switch
Grant 6,950,434 - Viswanath , et al. September 27, 2
2005-09-27
Segmention of buffer memories for shared frame data storage among multiple network switch modules
Grant 6,760,341 - Erimli , et al. July 6, 2
2004-07-06
Apparatus and method for resetting a retry counter in a network switch port in response to exerting backpressure
Grant 6,731,601 - Krishna , et al. May 4, 2
2004-05-04
Process for preparing cellulase and protease enzyme complex cud liquor from cattle and buffaloes cud for biodegradation of organic materialscud for biodegredation of organic materials
App 20040067571 - Krishna, Gopal
2004-04-08
Arrangement for transmitting packet data segments from a media access controller across multiple physical links
Grant 6,081,523 - Merchant , et al. June 27, 2
2000-06-27
Efficient memory management system for minimizing overhead in storage of data transmitted in a network
Grant 5,873,121 - Merchant , et al. February 16, 1
1999-02-16
Method and apparatus for adding a randomized propagation delay interval to an interframe spacing in a station accessing an ethernet network
Grant 5,850,525 - Kalkunte , et al. December 15, 1
1998-12-15
Method and apparatus for prioritizing traffic in half-duplex networks by selecting delay intervals from fixed ranges
Grant 5,822,538 - Krishna , et al. October 13, 1
1998-10-13
Rotating priority arrangement in an ethernet network
Grant 5,784,375 - Kalkunte , et al. July 21, 1
1998-07-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed